Home / France / DBV Technologies
DBV Technologies
Short position disclosed on September 10, 2026.
Evolution of the disclosed total
July 29, 2015 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Deep Track Biotechnology Master Fund, Ltd. | 1.98% | new | August 26, 2026 | ||
| Arrowstreet Capital, Limited Partnership | 0.90% | new | September 10, 2026 | ||
| Worldquant, LLC | 0.82% | new | September 1, 2026 |
In the United States DBVT (Nasdaq): 1,583,924 shares sold short on August 31, 2026.DBVTF (OTC): 417,700 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold DBV Technologies Titelia
Get the moves on DBV Technologies by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
The AMF column opens the filing the fund itself lodged, on the regulator own site.
Download 505 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.56% of the capital sold short
- Valeo 10.69% of the capital sold short
- Renault 9.59% of the capital sold short
- Teleperformance 8.38% of the capital sold short
- Viridien 7.04% of the capital sold short
- FDJ United 6.39% of the capital sold short
- Abivax 5.00% of the capital sold short
- Worldline 4.75% of the capital sold short
- Remy Cointreau 4.55% of the capital sold short
- Alstom 4.52% of the capital sold short
- Vusiongroup 3.99% of the capital sold short
- Forvia 3.95% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, DBV Technologies, source AMF, data as at September 10, 2026, https://www.quivad.com/action/dbv-technologies